ShareThis Page
Infants’ ibuprofen recalled from Walmart, CVS, Family Dollar |

Infants’ ibuprofen recalled from Walmart, CVS, Family Dollar

Tawnya Panizzi
Monmouth Junction, NJ, Tris Pharma, Inc. has voluntarily recalled Infants’ Ibuprofen Concentrated Oral Suspension sold under the Liquid ibuprofen sold at Walmart, CVS and Family Dollar labels.

Liquid ibuprofen for infants sold at Walmart, CVS and Family Dollar was recalled Wednesday, a New Jersey-based drug company announced .

The voluntary recall impacts three lots of infants’ liquid ibuprofen that can potentially have higher concentrations of medicine.

Tris Pharma Inc. said adverse effects could include nausea, vomiting and tinnitus.

The release said there is a remote possibility, because babies can be more susceptible to higher drug potencies, that they can be more vulnerable to permanent NSAID-associated renal injury.

Tris Pharma has not been notified of any illness related to the recalled medicine.

The ibuprofen, sold in 0.5-ounce bottles, was sold under the Equate, CVS Health and Family Wellness brands. They include:

• Equate: Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, 0.5 oz. bottle; sold by Walmart; lots 00717009A (expiration 02/19), 00717015A (expiration 04/19) and 00717024A (expiration 08/19); NDC: 49035-125-23.

• CVS Health: Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, 0.5 oz. bottle; sold by CVS Pharmacy; lot 00717024A (expiration 08/19); NDC: 59779-925-23.

• Family Wellness: Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, 0.5 oz. bottle; sold by Family Dollar; lot 00717024A (expiration 08/19); NDC: 55319-250-23.

Anyone with questions can call Tris customer service from 8 a.m. to 5 p.m. weekdays at 732-940-0358.

Tawnya Panizzi is a Tribune-Review staff writer. You can contact Tawnya at 412-782-2121, ext. 2, [email protected] or via Twitter @tawnyatrib.

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.